Cogent Biosciences, Inc.: operating lease liability

What this measure means

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Exact concept: us-gaap:OperatingLeaseLiability. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2019-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• Cogent Biosciences, Inc.: total assets
• Cogent Biosciences, Inc.: total liabilities
• Cogent Biosciences, Inc.: stockholders equity
• Cogent Biosciences, Inc.: cash and cash equivalents
• Cogent Biosciences, Inc.: net income or loss
• Cogent Biosciences, Inc.: operating cash flow
• Cogent Biosciences, Inc.: capital expenditure payments
• Cogent Biosciences, Inc.: financing cash flow
• Cogent Biosciences, Inc.: investing cash flow
• Cogent Biosciences, Inc.: retained earnings or deficit
• Cogent Biosciences, Inc.: basic weighted-average shares
• Cogent Biosciences, Inc.: diluted weighted-average shares
• Cogent Biosciences, Inc.: basic earnings per share
• Cogent Biosciences, Inc.: diluted earnings per share
• Cogent Biosciences, Inc.: net property, plant and equipment
• Cogent Biosciences, Inc.: share-based compensation expense
• Cogent Biosciences, Inc.: operating income or loss
• Cogent Biosciences, Inc.: current assets
• Cogent Biosciences, Inc.: current liabilities
• Cogent Biosciences, Inc.: current accounts payable
• Cogent Biosciences, Inc.: net current accounts receivable
• Cogent Biosciences, Inc.: research and development expense
• Cogent Biosciences, Inc.: common shares outstanding
• Cogent Biosciences, Inc.: cash including restricted cash
• Cogent Biosciences, Inc.: accumulated other comprehensive income or loss
• Cogent Biosciences, Inc.: operating lease right-of-use asset
• Cogent Biosciences, Inc.: gross property, plant and equipment
• Cogent Biosciences, Inc.: accumulated depreciation on property, plant and equipment
• Cogent Biosciences, Inc.: other noncurrent assets
• Cogent Biosciences, Inc.: prepaid expenses and other current assets
• Cogent Biosciences, Inc.: current contract liabilities
• Cogent Biosciences, Inc.: profit or loss including noncontrolling interests
• Cogent Biosciences, Inc.: comprehensive income or loss
• Cogent Biosciences, Inc.: net income available to common stockholders
• Cogent Biosciences, Inc.: general and administrative expense
• Cogent Biosciences, Inc.: depreciation expense
• Cogent Biosciences, Inc.: other nonoperating income or expense
• Cogent Biosciences, Inc.: nonoperating income or expense
• Cogent Biosciences, Inc.: interest paid, net
• Cogent Biosciences, Inc.: proceeds from issuing common stock
• Cogent Biosciences, Inc.: operating lease payments
• Cogent Biosciences, Inc.: change in accounts receivable
• Cogent Biosciences, Inc.: change in accounts payable

Inspect the source

Entity

Cogent Biosciences, Inc. / CIK 0001622229

Captured

2026-09-21T17:21:46.131Z

SEC response SHA-256

b9d94be9f80e344ba0abf34d342bf5afaf417f0105914abe7ecc95aac8b475bf

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001622229.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))